BSE filing, NSE: HEALTHX. Summary written from the filing by ALFA Finder's alert engine.
Sastasundar Ventures Ltd: key numbers
- Share price
- ₹281.30
- Market cap
- ₹894.8 Cr
- Revenue (annual)
- ₹1,319 Cr
- Net profit (annual)
- ₹1.18 Cr
- P/E (TTM)
- -44.3×Sector 53.7×
- Promoter holding
- 74.07%+0.00% QoQ
- FII holding
- 2.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sastasundar Ventures Ltd
All →Health X Platform Other Announcement
Health X Platform Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
Health X Platform Annual General Meeting
Health X Platform Limited held its 37th Annual General Meeting on September 28, 2026. Members transacted ordinary and special business, including financial statements and director re-appointments.
Health X Platform Other Announcement
Health X Platform Limited dispatched letters to shareholders with unregistered emails, providing web-links for the FY2025-26 Annual Report and 37th AGM notice.
Health X Platform Annual Report
Health X Platform Limited has filed its Annual Report for the financial year 2025-26. The company reported a consolidated total revenue of Rs. 1,319.27 Crore for the period.
Health X Platform Annual General Meeting
Health X Platform Limited will hold its 37th Annual General Meeting on September 28, 2026, via video conferencing. The meeting notice and annual report will be submitted later.
Health X Platform Earnings Call Transcript: Key Takeaways
Health X is aggressively scaling its digital B2B and B2C pharmacy platforms, showing strong top-line momentum while burning cash on technology and geographical expansion.
- Call
- Guides 100% growth
Other capital structure change announcements
All →Acetech E-Commerce Capital Structure Change
Acetech E-Commerce submitted a Draft Letter of Offer for a proposed Rights Issue of equity shares up to Rs. 4000 Lakhs. The filing is a preliminary rights-issue step with issue price and ratio still blank.
- Value
- ₹40.00 Cr
Indrayani Biotech Capital Structure Change
Indrayani Biotech allotted 83,64,036 rights equity shares at Rs 15 (75,03,333 fully paid) and Rs 3.75 (8,60,703 partly paid). Issue receipts total about Rs 11.58 Crore.
- Value
- ₹11.58 Cr
Shlokka Dyes Capital Structure Change
Shlokka Dyes proposed raising its authorised capital to 2.9 crore shares, pending approval at a 28 November 2026 meeting. No fresh capital has been raised yet.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ received BSE in-principle approval for its Rights Issue and has convened a board meeting on 4 November 2026 to fix the issue price and record date. The issue was earlier approved for up to Rs 40 Crore.
DCW Capital Structure Change
DCW Ltd bought back 155,000 equity shares on NSE on 03-Nov-2026 at an average price of Rs.45.18. The daily report puts the day's buyback spend at about Rs.0.70 Crore.
- Value
- ₹0.70 Cr
NCL Research and Financial Services Capital Structure Change
GCM Capital Advisors and PACs disclosed selling 8,00,000 NCL Research shares, reducing holding to 5.49%. Non-promoter transaction, no consideration stated.